These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. PEG conjugates in clinical development or use as anticancer agents: an overview. Pasut G; Veronese FM Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438 [TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates. Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660 [TBL] [Abstract][Full Text] [Related]
7. Polymer-drug conjugates: present state of play and future perspectives. Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841 [TBL] [Abstract][Full Text] [Related]
8. Polymer therapeutics: concepts and applications. Haag R; Kratz F Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775 [TBL] [Abstract][Full Text] [Related]
9. Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile. Siddalingappa B; Benson HA; Brown DH; Batty KT; Chen Y PLoS One; 2015; 10(3):e0118824. PubMed ID: 25799413 [TBL] [Abstract][Full Text] [Related]
12. Design and development of polymer conjugates as anti-angiogenic agents. Segal E; Satchi-Fainaro R Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248 [TBL] [Abstract][Full Text] [Related]
13. Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-elimination. Greenwald RB; Yang K; Zhao H; Conover CD; Lee S; Filpula D Bioconjug Chem; 2003; 14(2):395-403. PubMed ID: 12643750 [TBL] [Abstract][Full Text] [Related]
14. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. Duncan R; Vicent MJ; Greco F; Nicholson RI Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096 [TBL] [Abstract][Full Text] [Related]
18. The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution. Dyawanapelly S; Junnuthula VR; Singh A Curr Drug Metab; 2015; 16(7):522-37. PubMed ID: 25523548 [TBL] [Abstract][Full Text] [Related]
19. Polymer-drug conjugates: current status and future trends. Greco F; Vicent MJ Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750 [TBL] [Abstract][Full Text] [Related]